Internet messaging company Twitter Inc. filed an amended Form S-1 with the SEC on Thursday setting a price range of $17 to $20 for the firm’s upcoming initial public offering (IPO). Twitter will offer 70 million shares and underwriters have an option for another 10.5 million.
The maximum valuation for the company is $11.1 billion, a far cry from the $81 billion valuation of Facebook Inc. (NASDAQ: FB) at its star-crossed IPO and less even the daily deals website Groupon Inc. (NASDAQ: GRPN). On a fully-diluted basis the company’s valuation increases to about $14 billion.
Net proceeds after underwriters’ commissions are expected to total about $1.44 billion at a price of $18.50 a share. The company’s stock will trade on the NYSE under the ticker symbol ‘TWTR.’
Now that the IPO price is set, the Twitter roadshow can begin. The Wall Street Journal notes that company executives and bankers will meet with potential investors in New York on Tuesday and Wednesday, in Boston on Thursday, and in Chicago on Friday. The following week the company will hit San Francisco, Los Angeles, and Denver.
Twitter and its underwriters are valuing the company below the company’s September estimate of its per share value at $20.62. The company may face some tough sledding selling its slowing growth rate and its lack of profits. The tentative IPO date is November 6th.
“The Next NVIDIA” Could Change Your Life
NVIDIA has returned 250-fold in the past 10 years as artificial intelligence took off.
But if you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.
The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”
The report outlines key breakthroughs in AI and the stocks ready to dominate the next wave of growth. The report is absolutely free. Simply enter your email below
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.